What is Regenerative Medical Solutions?

Regenerative Medical Solutions (RMS) is a privately held biotechnology company based in Madison, Wisconsin, developing a functional cure for diabetes using induced pluripotent stem cell (iPSC) technology. Founded in 2012, RMS is advancing a regenerative medicine platform designed to restore the body’s natural ability to produce insulin, with the goal of eliminating patients’ lifelong dependence on insulin injections.

The company was built on more than 15 years of foundational academic research conducted at the University of Wisconsin–Madison, and its work is backed by a substantial intellectual property portfolio, NIH grant funding, and a leadership team with deep experience in stem cell biology, pancreatic transplantation, and biotechnology commercialization.

RMS’s primary focus is the development of an iPSC-derived cellular therapeutic for Type 1 and Type 2 diabetes. The company also offers research products and biotech consulting services for organizations working in diabetes research and regenerative medicine.

Learn more about RMS on our About page.